The Oncology Institute (NASDAQ:TOI) reported quarterly losses of $(0.08) per share which missed the analyst consensus estimate of $(0.06) by 33.33 percent. This is a 46.67 percent increase over losses of $(0.15) per share from the same period last year. The company reported quarterly sales of $161.282 million which beat the analyst consensus estimate of $155.193 million by 3.92 percent. This is a 34.62 percent increase over sales of $119.802 million the same period last year.